3/20/2024 | 300490000000 | LENALIDOMIDE (REVLIMID) 5 MG 3*7 CAPSULE/S FOR ORAL USE | 3 | UNIT | 5095 | N/A | JOHNSON AND JOHNSON SIHHİ MALZEME SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
3/20/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 25 MG 3X7 CAPS. PRODUCT USED IN FOR ORAL USE CLINICAL TRIALS
| 2 | Units | 13619.74 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |
3/5/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 25 MG 3X7 CAPS. PRODUCT USED IN FOR ORAL USE CLINICAL TRIALS
| 3 | Units | 20281.27 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |
3/27/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 10 MG 3X7 CAPSULES FOR ORAL USE - PRODUCT USED IN CLINICAL TRIALS
| 3 | Units | 17578.78 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |
3/13/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 10 MG 3X7 CAPS. PRODUCT USED IN FOR ORAL USE CLINICAL TRIALS
| 3 | Units | 17467.35 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |
3/27/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 25 MG 3X7 CAPSULES FOR ORAL USE - PRODUCT USED IN CLINICAL TRIALS
| 3 | Units | 20305.14 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |
3/13/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 25 MG 3X7 CAPS. PRODUCT USED IN FOR ORAL USE CLINICAL TRIALS
| 3 | Units | 20170.82 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |
3/4/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 10 MG 3X7 CAPS. PRODUCT USED IN FOR ORAL USE CLINICAL TRIALS
| 3 | Units | 17645.41 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |
3/11/2024 | 300490000000 | LENALIDOMIDE (REVLIMID) 10 MG 3*7 CAPSUL/ES FOR ORAL USE | 3 | UNIT | 17002 | N/A | JOHNSON AND JOHNSON SIHHİ MALZEME SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
3/5/2018 | 300490000000 | LENALIDOMIDE (REVLIMID) 10 MG 3X7 CAPS. PRODUCT USED IN FOR ORAL USE CLINICAL TRIALS
| 4 | Units | 23416.47 | N/A | JOHNSON AND JOHNSONSIHHI MALZ.SAN.VE TIC.LTD.STI. |